11 abstracts found.



Results filter

Evolutionary tales in leukaemia

Year:

Session type: ,

Mel Greaves1

1The Institute of Cancer Research, Sutton, UK


T Cell Engineering as Therapy for Cancer and HIV: Our Synthetic Future

Year:

Session type: ,

Carl June1

1University of Pennsylvania, Philadelphia, PA, USA


Epigenetic Targets in Cancer

Year:

Session type: ,

Kristian Helin1

1University of Copenhagen, Copenhagen, Denmark


Heterogeneity, drug resistance and clonal evolution of colorectal cancers

Year:

Session type: ,

Alberto Bardelli1

1University of Toringo, Turin, Italy


“Rethinking” Cancer as a Complex Adaptive System”

Year:

Session type: ,

Anna Barker1

1Complex Adaptive Systems Institute, Arizona, USA


Is late diagnosis of cancer real and if so what can we do about it?”

Year:

Session type: ,

Harpal Kumar1

1Cancer Research UK, London, UK


Probing the transcriptional consequences of Ras and Rho activation

Year:

Session type: ,

Richard Treisman1,2

1Cancer Research UK London Research Institute, London, UK,2Francis Crick Institute, London, UK


Hormone Therapy for Prostate Cancer

Year:

Session type: ,

Charles Sawyers1

1Memorial Sloan Kettering Cancer Center, New York, NY, USA


Genomic tests to personalized therapy of patients with metastatic breast cancer

Year:

Session type: ,

fabrice andre1

1gustave roussy, villjuif, France


Technological Developments in Radiotherapy

Year:

Session type: ,

Uwe Oelfke1

1Institute of Cancer Research, Sutton, Surrey, UK


Big data and patient reported outcome measures (PROMs)

Year:

Session type: ,

Amy Abernethy1

1Flatiron Health, New York, NY, USA